CHAIRPERSONS:
Cornelia M. Ulrich, Fred Hutchinson Cancer Research Center, Seattle, WA
Stephen J. Chanock, National Cancer Institute, Bethesda, MD
PROGRAM COMMITTEE:
Lon R. Cardon, Fred Hutchinson Cancer Research Center, Seattle, WA
Christopher A. Haiman, USC/Norris Comprehensive Cancer Center, Los Angeles, CA
M. Elena Martinez, Arizona Cancer Center, Tucson, AZ
Julie A. Ross, University of Minnesota Cancer Center, Minneapolis, MN
Thomas A. Sellers, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Alice S. Whittemore, Stanford University School of Medicine, Stanford, CA
Molecular epidemiologists and geneticists now have the tools on hand to assess comprehensively genetic susceptibility for cancer risk. The two state-of the art approaches – genome-wide association studies (GWAS) and candidate pathway studies – provide complementary types of information and have different strengths and limitations. With technologies and statistical methods for both of these approaches rapidly advancing, we face the challenge of mining the enormous databases available in order to advance the field. Key questions to be addressed are the study designs for large-scale genetic investigation and the integration of environmental factors in order to understand the complex interactions underlying cancer susceptibility.
This conference will showcase researchers from different disciplines, who have excelled in addressing these challenges and are creative in developing new methods. Leaders in the field will present the most up-to-date results from genome-wide and candidate pathway studies. We anticipate that speakers and attendees from diverse disciplines will engage in stimulating discussions that will help propel the field of molecular and genetic epidemiology forward. We hope that you will be able to join us in Arizona for this exciting program!
Know a colleague who might be interested in this conference?